Subcutaneous insulin aspart vs intravenous regular insulin
All‐cause mortality (N) Mean hospital stay: 2‐7 days
1 finding from 1 review
- Subcutaneous rapid‐acting insulin analogues for diabetic ketoacidosis 2016 · Cochrane Headline outcomes onlyno estimate extracted1 study · 45 participantsLow